Stem cells and business development feature in March AusBiotech journal
AusBiotech is pleased to provide the latest edition of the Australasian Biotechnology e-journal (Volume 23, Number 1), featuring:
- The potential of stem cell therapies - A reflection on what we have achieved so far and what the future holds for the game-changing field of biotechnology;
- The changing landscape of licensing deal collaborations and what it means for business development;
- A full report on the AusBiotech 2012 national conference.
For your link to the AusBiotech journal for March 2013, click here. You can access Australasian Biotechnology as many times as you like, so save the link to your favourites. The ‘Save Magazine’ function enables you to save a PDF to your desktop in seconds, so you can keep it on file or easily print it.
The e-journal also has regular features such as the AusBiotech Chair and CEO Report, and AusBioSTOCK, an exclusive report from Baillieu Holst Stockbroking’s Joanna Hill.
Hard copies are available by contacting the editor, Lorraine Chiroiu, at lchiroiu@ausbiotech.org. The next edition will be published in July 2013.
Cancer drug eliminates bone metastasis in lab models
Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...
TGA rejects Alzheimer's drug due to safety concerns
The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
